TNF and neoplasm: By now, studies have been carried out to evaluate the anticancer efficacy of TNF-α in several tumor types; however, despite the promising anticancer potential, in clinical trials, TNF-α has not been a very successful anticancer agent, mainly because of its severe dose-limiting toxicity after systemic administration (Ham et al., 2016; Shen et al., 2018).